Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival

Additional Metadata
Keywords	Allogeneic stem cell transplantation, Myeloma, Prognosis
Persistent URL	doi.org/10.3324/haematol.2015.128728, hdl.handle.net/1765/84973
Journal	Haematologica
Organisation	Department of Hematology
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Lokhorst, H., van der Holt, B., Cornelissen, J., Kersten, M. J., van Oers, M., Raymakers, R., Minnema, M., Zweegman, S., Bos, G. M. J., Schaap, N., Wittebol, S., de Weerdt, O., Ammerlaan, R.& Sonneveld, P. (2015). Reduced relapse rate in upfront tandem autologous/reduced-intensity allogeneic transplantation in multiple myeloma only results in borderline non-significant prolongation of progression-free but not overall survival. Haematologica, 100(12), e508–e510.https://doi.org/10.3324/haematol.2015.128728

Publication